Status:
NOT_YET_RECRUITING
The World Federation of Hemophilia Gene Therapy Registry
Lead Sponsor:
World Federation of Hemophilia
Conditions:
Hemophilia
Eligibility:
All Genders
Up to 100 years
Brief Summary
The aim of the WFH GTR is to provide a database in which long-term data on PWH who receive gene therapy from around the world, will be collected and housed.
Detailed Description
The first gene therapy product for hemophilia is expected to receive marketing authorization in 2020, with several others following closely behind. With these new therapies hitting the market in the n...
Eligibility Criteria
Inclusion
- People with hemophilia who have received a gene therapy product
Exclusion
- None
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2050
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04883710
Start Date
January 1 2022
End Date
January 1 2050
Last Update
May 12 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.